Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3062761000168119 | Visipaque (iodixanol 550 mg / 1 mL) injection, 6 x 200 mL bottles (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3062771000168113 | Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | Is a | Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | has TPUU | Visipaque 550 mg (iodine 270 mg)/mL injection, 200 mL bottle | true | Inferred relationship | Some | 1 | |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | has container type | bottle | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 6 x 200 mL bottles | has TP | Visipaque | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR